Last Funding Type: Series A
Funding Status: Early Stage Venture
Headquarters: United States
Founded Date: 2020-01-01
Last Funding Date: 2022-06-08
Total Funding: 37200000.0
Investors Number: 7.0
Industry: Early Drug Development